Indian markets ended lower on Thursday following the U.S. imposition of 26% tariffs, despite gains in pharma stocks that were exempt from these duties. However, positive domestic economic data and falling crude oil prices helped cushion some of the impact, keeping the broader market resilient.
Comments
Post a Comment